TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL

被引：0
|
作者：
Lavrador, M. [1 ]
Araujo, B. [1 ]
Araujo, C. [1 ]
Melo, M. [1 ]
Baptista, C. [1 ]
Barros, L. [1 ]
Paiva, I. [1 ]
机构：
[1] Ctr Hosp Univ Coimbra, Endocrinol, Coimbra, Portugal
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP241 / #5
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE
    Cakmak, Ramazan
    Oghyanous, Golpouneh Alizad
    Selcukbiricik, Ozlem Soyluk
    Karsidag, Kubilay
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2025, 88 (01): : 45 - 52
  • [32] SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus
    Lukic, Nikola
    Macvanin, Mirjana T.
    Gluvic, Zoran
    Rizzo, Manfredi
    Radak, Djordje
    Suri, Jasjit S.
    Isenovic, Esma R.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (30) : 4781 - 4806
  • [33] SGLT-2 and SGLT-1 expression in renal tissue of patients with type 2 diabetes
    Solini, A.
    Rossi, C.
    Proietti, A.
    Ferrannini, E.
    DIABETOLOGIA, 2016, 59 : S351 - S351
  • [34] Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors
    Egan, Aoife M.
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (02) : JC2 - JC2
  • [35] SGLT-2 Inhibitors and GLP-1-RA reduce Risk of NAFLD in Type-2-Diabetes
    不详
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (04) : 250 - 251
  • [36] SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation
    Arnold, Michael J.
    Buelt, Andrew
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (06) : 675 - 677
  • [37] RE: DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES ON SGLT-2 INHIBITORS: AN ONGOING CONCERN
    Bell, David S. H.
    ENDOCRINE PRACTICE, 2018, 24 (01) : 126 - 126
  • [38] SGLT-2 inhibitors on cardiac autonomic function in individuals with and without type 2 diabetes mellitus
    Ozel, Hasan Fehmi
    Alpay, Suheda
    Asker, Emre
    Gultekin, Elif Sidal
    Kazdagli, Hasan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2025, 39 (05)
  • [39] SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?
    Bonnet, Fabrice
    Scheen, Andre J.
    DIABETES & METABOLISM, 2014, 40 : S1 - S3
  • [40] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
12345